Elutia Receives $8 Million Payment from Boston Scientific, Funded into 2029
Elutia Inc. announced it has received the full $8 million held in escrow from the sale of its BioEnvelope business to Boston Scientific, which fully funds the company into 2029.
Story updates
08:48:28 PM UTC
SquawkNews
Elutia received the full $8M escrow from the 2025 sale of its BioEnvelope business to Boston Scientific and says it is funded through the first full year of NXT-41x launch and into 2029, without an equity offering. FDA clearance for NXT-41x is expected in H1 2027.Material DetailsContext by AI Analy…